Search Results - herpes+simplex+virus+(hsv)

2 Results Sort By:
Isolation and Application of a Llama-derived Single Domain Antibody Binding to Glycoprotein D of HSV-2
Treatment and Preventative for Herpes Simplex Virus-2JHU REF: 12627Invention Novelty: This technology is an antibody-toxin fusion therapeutic for treatment and prevention of HSV-2.Value Proposition:HSV infects 85% of the global population and 73% of the American population. Currently, there is no cure for HSV infection. This technology is an antibody-based...
Published: 3/13/2025   |   Inventor(s): Eileen Geoghegan, Richard Markham
Keywords(s): Antibodies, Biologics, Disease Indication, Herpes Simplex Virus, Herpes Simplex Virus (HSV), Infectious Diseases, Therapeutic Matter, Therapeutic Substance, Therapeutics, Viral Infections
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > Herpes Simplex Virus, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Biologics, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities
Development of a Combinational Paradigm Combating HIV, HIV/HSV or HIV/HPV Infections in Humans
Technical Details: WHO report has stated that there are 39.5 million people currently HIV positive worldwide. Of these, 4.3 million have been infected in the year 2006 alone. AIDS death reached 2.9 million this year which is the highest ever reported in any year. There are 40,000 new AIDS cases a year in U.S. along. The anti-HIV compounds that are currently...
Published: 3/13/2025   |   Inventor(s): Ru Chih Huang, Ibrahim Abd-Elazem
Keywords(s): Antagonists/Inhibitors, Cancers, Disease Indication, Herpes Simplex Virus, Herpes Simplex Virus (HSV), HIV, HIV/AIDS, Infectious Diseases, Natural compounds, Non-novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics, Viral Infections
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Infectious Diseases > Herpes Simplex Virus, Clinical and Disease Specializations > Infectious Diseases > HIV/AIDS, Clinical and Disease Specializations > Infectious Diseases > Viral Infections, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum